Prostate Cancer Trial, Recruiting (NCT07484971)

Prostate Cancer Trial, Recruiting NCT07484971 Sponsor: Société Algérienne de Formation et Recherche en Oncologie Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07484971 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 19 years or older.
People who have been diagnosed with prostate cancer confirmed through a tissue sample (biopsy) and/or biological testing.
People whose cancer care is being managed within one of the oncology departments taking part in this trial.
People who have given their written agreement to participate.

Who may not be able to join:

People whose prostate cancer is a type other than carcinoma (a specific cancer cell type — confirm with trial site if unsure which type applies).
People who have a secondary tumour, meaning a cancer that has spread from another part of the body.
People who are already taking part in another interventional clinical study (a study that involves a treatment or procedure being tested).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +213 25 20 90 72

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07484971

Sponsor: Société Algérienne de Formation et Recherche en Oncologie

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +213 25 20 90 72

More information: https://clinicaltrials.gov/study/NCT07484971

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 19 years or older.
People who have been diagnosed with prostate cancer confirmed through a tissue sample (biopsy) and/or biological testing.
People whose cancer care is being managed within one of the oncology departments taking part in this trial.
People who have given their written agreement to participate.

Who may not be able to join:

People whose prostate cancer is a type other than carcinoma (a specific cancer cell type — confirm with trial site if unsure which type applies).
People who have a secondary tumour, meaning a cancer that has spread from another part of the body.
People who are already taking part in another interventional clinical study (a study that involves a treatment or procedure being tested).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Société Algérienne de Formation et Recherche en Oncologie

Registry

ClinicalTrials.gov

Start date

21 July 2025

Est. completion

21 July 2026

Where this trial is recruiting

Algeria

Primary endpoints

Socio-demographic characteristics of patients with prostate cancer in Algeria; Personal and family history of cancer; Environmental and occupational exposures; Smoking history; Alcohol consumption; Initial symptoms and circumstances of diagnosis; International Prostate Symptom Score (IPSS); Evolutionary status of patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov